Goldman Sachs moves to Not Rated on Fulcrum Therapeutics after study failure
PremiumThe FlyGoldman Sachs moves to Not Rated on Fulcrum Therapeutics after study failure
2M ago
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
2M ago
Moderna, Halliburton downgraded: Wall Street’s top analyst calls
Premium
The Fly
Moderna, Halliburton downgraded: Wall Street’s top analyst calls
2M ago
Fulcrum Therapeutics downgraded to Underperform from Neutral at BofA
PremiumThe FlyFulcrum Therapeutics downgraded to Underperform from Neutral at BofA
2M ago
Fulcrum Therapeutics downgraded to Hold from Buy at Stifel
Premium
The Fly
Fulcrum Therapeutics downgraded to Hold from Buy at Stifel
2M ago
Fulcrum sinks 63% to $3.30 after facioscapulohumeral muscular dystrophy failure
Premium
The Fly
Fulcrum sinks 63% to $3.30 after facioscapulohumeral muscular dystrophy failure
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100